INFLUVAC

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Hong Kong, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug INFLUVAC contains one active pharmaceutical ingredient (API):

1 Influenza, inactivated, surface antigen

Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500213040030713, 500215070034103, 500215070034203
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 20-MBE-0315
Country: EE	Ravimiamet	Identifier(s): 1165418, 1165429
Country: HK	Department of Health Drug Office	Identifier(s): 51268
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1017705, 1017706
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 204706
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11227
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100224699
Country: SG	Health Sciences Authority	Identifier(s): 13177P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 18243011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699820960117
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.1/581